Myriad Genetics (MYGN) Net Cash Flow (QoQ) (2009 - 2026)
Myriad Genetics (MYGN) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600.00% |
| Dec 31, 2025 | -105.06% |
| Sep 30, 2025 | 497.21% |
| Jun 30, 2025 | -62.73% |
| Mar 31, 2025 | -492.86% |
| Dec 31, 2024 | -45.10% |
| Sep 30, 2024 | 464.29% |
| Jun 30, 2024 | 95.94% |
| Mar 31, 2024 | -162.50% |
| Dec 31, 2023 | 303.69% |
| Sep 30, 2023 | -154.97% |
| Jun 30, 2023 | 1,508.57% |
| Mar 31, 2023 | 92.22% |
| Dec 31, 2022 | -1,000.00% |
| Sep 30, 2022 | 108.45% |
| Jun 30, 2022 | 36.07% |
| Mar 31, 2022 | -153.70% |
| Dec 31, 2021 | -120.60% |
| Sep 30, 2021 | 694.63% |
| Jun 30, 2021 | -194.60% |